Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$30.98 – $37.25
1% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $470.3M | $488.5M | $551.4M | $574.3M | $593.4M | $689.7M | $668.8M | $672.8M |
| Cost of revenue | $287.6M | $302.5M | $339.8M | $342.1M | $367.4M | $450.4M | $490.1M | $639.5M |
| Gross profit | $182.7M | $186.0M | $211.6M | $232.2M | $226.0M | $239.3M | $178.7M | $672.8M |
| Gross margin | 38.8% | 38.1% | 38.4% | 40.4% | 38.1% | 34.7% | 26.7% | 100.0% |
| R&D | $51.4M | $60.9M | $71.4M | $68.1M | $72.9M | $93.3M | $27.8M | $21.4M |
| Operating income | $41.8M | $44.3M | $45.4M | $61.5M | $56.6M | $40.5M | $6.4M | $42.4M |
| EBITDA | $31.4M | $65.5M | $68.0M | $82.3M | $79.8M | $87.5M | $73.7M | $93.7M |
| Net income | $42.7M | $7.8M | $35.3M | $47.3M | $40.9M | $33.3M | $7.9M | $19.3M |
| Net margin | 9.1% | 1.6% | 6.4% | 8.2% | 6.9% | 4.8% | 1.2% | 2.9% |
| EPS (diluted) | 0.69 | 0.12 | 0.54 | 0.72 | 0.62 | 0.50 | 0.12 | 0.25 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $672M | $1.04 | $0.97–$1.11 | 1 |
| 2027 | $680M | $1.02 | $0.95–$1.09 | 1 |
| 2028 | $695M | $1.13 | $1.05–$1.21 | 1 |
| 2029 | $733M | $1.34 | $1.24–$1.43 | 1 |
Forward consensus · source: Financial Modeling Prep
GENUS PLC ORD
No one on the platform currently holds GENSF.
No tracked institution reports a position in GENSF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-06 | $0.1120 | 2026-03-27 |
| 2025-11-07 | $0.2170 | 2025-12-05 |
| 2025-03-07 | $0.1030 | 2025-04-04 |
| 2024-11-08 | $0.2170 | 2024-12-06 |
| 2024-02-29 | $0.1030 | 2024-03-28 |
| 2023-11-09 | $0.2170 | 2023-12-08 |
No one on the platform has traded GENSF yet.
| $1.1B |
| — |
| GTBIFGreen Thumb Industries Inc. | $7.64 | +2.00% | $1.8B | — |
| MEOBFMesoblast Limited | $1.55 | +0.00% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 33.8× earnings vs its 90.5× historical median P/E.
Fair value ≈ $83.25 · price $31.07 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.